Idexx Laboratories

IDXXNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$46.219 B

$586.67 -0.56%

Close of 7 Aug 2026

Revenue

$4.30B

#746 by revenue

Earnings

$1.06B

#376 by earnings

Shares outstanding

78,781,116

Latest filing cover page

P/E ratio

43.6

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances — ranked by market cap

All 19 →

#1Idexx LaboratoriesIDXX$46.2B
#2LantheusLNTH$6.57B
#3Oruka TherapeuticsORKA$5.96B
#4Celldex TherapeuticsCLDX$3.27B
#5NeogenNEOG$2.50B

Where these numbers come from

Share counts and financials for Idexx Laboratories are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.